https://www.selleckchem.com/pr....oducts/tiplaxtinin-p
The relationship between metabolic syndrome (MetS) and the risk of fracture is a matter of debate. This work aimed to determine the impact of MetS and its components on the risk of hospitalized fractures, during a median follow-up of 15.9 years. A total of 7,520 participants (4,068 women) 30 years or older entered the study. Multivariable Cox proportional hazards regression were applied for data analysis. The prevalence of MetS was 40.0% and 40.4% in men and women, respectively. During the follow-up, hospitalized fracture wa